share_log

天演药业宣布将于九月出席多个重要投资者会议

Tianyan Pharmaceutical announced that it will attend several important investor conferences in September.

PR Newswire ·  Aug 29 20:00

Suzhou, China and San Diego, usa, August 29, 2024 / PRNewswire / - Tanyan Pharmaceuticals (referred to as "Company" or "Tanyan") (NASDAQ stock code: ADAG) is a platform-driven clinical-stage biopharmaceutical company dedicated to discovering and developing novel therapies based on original antibodies. The company announced today that Dr. Lu Peizhi, CEO, Chairman and Chief R&D Officer of Tanyan, will attend several investor conferences in New York, usa in September. During the conference, the company's management team will also participate in related one-on-one investor meetings.

The 22nd Morgan Stanley Global Medical Health Annual Conference

  • Fireside Chat: September 6th (Friday) 7:45-8:20 am (Eastern Time, usa)

The 26th H.C. Wainwright Annual Global Investment Summit

  • Fireside Chat: Monday, September 9th, 8:30-9:00 AM (Eastern Time)

2024 Cantor Fitzgerald Global Medical Health Conference

  • Fireside Chat: Wednesday, September 18th, 2:30-3:00 PM (Eastern Time)

Accessible on Tianyan Investor Relations website, watch the webcast:Link(Supports up to 30 days of playback).

About Tianyao Pharmaceutical

Tianyao Pharmaceutical (NASDAQ Stock Code: ADAG) is a biopharmaceutical company that is platform-driven and develops clinical-stage products with independent platform output. The Company is committed to discovering and developing new cancer immunotherapies based on original antibodies. Leveraging computational biology and artificial intelligence, Tianyao Pharmaceutical has established a unique and original antibody product line focused on new cancer immunotherapies to address unmet clinical needs. It has formed strategic partnerships with many well-known global partners and empowered new drug research and development with its diverse original cutting-edge technologies.

For more information, please visit: And pay attention to Tianyan PharmaceuticalWeChat,LinkedInandTwitterOfficial account.

SAFEbody is a registered trademark of Tianyao Pharmaceutical in the United States, China, Australia, Japan, Singapore, and the European Union.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment